Design Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Design Therapeutics

10/05/2022 08:27

* Design Therapeutics Inc  DSGN.OQ  reported a quarterly
adjusted
loss of 24 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 22 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Design Therapeutics Inc's reported EPS for the quarter was
a
loss of 24 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Design Therapeutics Inc shares had fallen by 31.5% this
quarter and lost 48.3% so far this year.
    * The company reported a quarterly loss of $13.27 million.
    * Wall Street's median 12-month price target for Design
Therapeutics Inc is $30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated May 10 at 07:27 a.m.  ​All
figures in US dollars unless otherwise stated